AUTHOREA
Log in Sign Up Browse Preprints

loading page

Sequential administration of anti-VEGF therapy after craniospinal irradiation and intrathecal chemotherapy for the treatment of central nervous system AML relapse after allo-HSCT: a case report and literature review
  • +5
  • Hanyu Cao,
  • Tao Tao,
  • Xiang-Dong Shen,
  • Lian Bai,
  • Chao-Ling Wan,
  • De-Pei Wu,
  • Jin-Li Li,
  • Shengli Xue
Hanyu Cao
First Affiliated Hospital of Soochow University

Corresponding Author:[email protected]

Author Profile
Tao Tao
the Fifth People’s Hospital of Suzhou
Author Profile
Xiang-Dong Shen
First Affiliated Hospital of Soochow University
Author Profile
Lian Bai
First Affiliated Hospital of Soochow University
Author Profile
Chao-Ling Wan
First Affiliated Hospital of Soochow University
Author Profile
De-Pei Wu
First Affiliated Hospital of Soochow University
Author Profile
Jin-Li Li
First Affiliated Hospital of Soochow University
Author Profile
Shengli Xue
The First Affilicated Hospital of Soochow University
Author Profile

Abstract

There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenance therapy for those with CNS leukemia.

Peer review status:ACCEPTED

12 Dec 2021Submitted to Clinical Case Reports
Show details
Hide details
13 Dec 2021Submission Checks Completed
13 Dec 2021Assigned to Editor
23 Dec 2021Reviewer(s) Assigned
04 Jan 2022Review(s) Completed, Editorial Evaluation Pending
05 Jan 2022Editorial Decision: Revise Minor
11 Jan 20221st Revision Received
12 Jan 2022Submission Checks Completed
12 Jan 2022Assigned to Editor
12 Jan 2022Review(s) Completed, Editorial Evaluation Pending
18 Jan 2022Editorial Decision: Accept